BOULDER, Colo. (AP) _ Fresh Tracks Therapeutics, Inc. (FRTX) on Thursday reported a loss of $6 million in its third quarter.

On a per-share basis, the Boulder, Colorado-based company said it had a loss of $2.07.

The drug developer posted revenue of $486,000 in the period.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on FRTX at https://www.zacks.com/ap/FRTX

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News